Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2014
10/02/2014US20140294927 Synthetic nanostructures including nucleic acids and/or other entities
10/02/2014US20140294925 Formulations combining ramoplanin and rhamnolipids for combating bacterial infection
10/02/2014US20140294924 Regeneration of Pancreatic Islets and Reversal of Diabetes by Islet Transcription Factor Genes Delivered In Vivo
10/02/2014US20140294922 Compound with antibacterial activity
10/02/2014US20140294921 Composition for tipical use for treating skin disorders
10/02/2014US20140294920 Transdermal propranolol patch for treatment of malignant melanoma
10/02/2014US20140294916 Methylphenidate Extended Release Chewable Tablet
10/02/2014US20140294903 Methods and compositions for treating hiv-associated diarrhea
10/02/2014US20140294897 Potent lna oligonucleotides for the inhibition of hif-1a expression
10/02/2014US20140294892 Construction of west nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by west nile virus
10/02/2014US20140294873 Small molecule screen for inhibitors of nfat: ap-1: dna interactions
10/02/2014US20140294870 Autoimmune and Inflammatory Disorder Therapy
10/02/2014US20140294868 Pyrrolobenzodiazepines and conjugates thereof
10/02/2014US20140294860 Means and methods for treating and/or preventing natural ahr ligand-dependent cancer
10/02/2014US20140294856 Combination treatment comprising a hdac6 inhibitor and an akt inhibitor
10/02/2014US20140294842 Assays, Methods and Means
10/02/2014US20140294830 Method of combination therapy using an egfr antagonist and anti-c-met antibody
10/02/2014US20140294829 Anti-ngf antibodies for the treatment of various disorders
10/02/2014US20140294818 Pgam1 inhibitors and methods related thereto
10/02/2014US20140294816 Combination therapy for the treatment of ocular neovascular disorders
10/02/2014US20140294808 Treating cancer with hsp90 inhibitory compounds
10/02/2014US20140294806 Methods and compositions for treating cancers having acquired resitance to prior chemotherapeutic and targeted drugs using carboxyamidotriazole orotate
10/02/2014US20140294805 Novel compounds and compositions for the inhibition of nampt
10/02/2014US20140294804 Methods of treating pain
10/02/2014US20140294799 Use of compositions having a low polyamine content in the prevention or treatment of adverse effects linked to cancer treatment
10/02/2014US20140294798 RbAp48 TRANSGENIC MICE FOR DRUG DISCOVERY IN AGE-RELATED MEMORY DECLINE
10/02/2014US20140294795 Nutritional Composition
10/02/2014US20140294790 Method of preventing, controlling and ameliorating urinary tract infections and supporting digestive health by using a synergistic cranberry derivative, a d-mannose composition and a proprietary probiotic blend
10/02/2014US20140294789 Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
10/02/2014US20140294787 Extensional viscosity to promote safe swallowing of food boluses
10/02/2014US20140294769 2',4'-fluoro nucleosides for the treatment of hcv
10/02/2014US20140294767 Method of treating hcv infection with a small molecule chk2 inhibitor
10/02/2014US20140294766 Anti-Infective Agents and Uses Thereof
10/02/2014US20140294765 Lsr antibodies, and uses thereof for treatment of cancer
10/02/2014US20140294764 Compounds and compositions used to epigenetically transform cells and methods related thereto
10/02/2014US20140294763 Peptidomimetic protease inhibitors
10/02/2014US20140294760 Novel cell and therapeutical and diagnostical methods based thereon
10/02/2014US20140294753 Novel use of ganodermic acids for treating cancer
10/02/2014US20140294751 Hemocompatibility Modifiers for Cross-Linked Polymeric Material
10/02/2014US20140294750 Aqueous pharmaceutical compositions containing borate-polyol complexes
10/02/2014US20140294737 Treatment of rhinitis
10/02/2014US20140294733 Multifunctional small molecules
10/02/2014US20140294726 Methods for diagnosing and treating alzheimer's disease by administering an anti-angiogenic agent
10/02/2014US20140290647 Intranasal administration of agents with pro-inflammatory activity for the therapy of neurological disorders
10/01/2014EP2784078A1 Benzoxepin pi3k inhibitor compounds and methods of use
10/01/2014EP2784077A1 Norepinephrine and selective serotonin receptor blocker and use thereof
10/01/2014EP2784076A1 Dimeric SMAC mimetics
10/01/2014EP2784075A1 Hepatitis C virus inhibitors
10/01/2014EP2784074A1 Pyrazole compound and use thereof for medical purposes
10/01/2014EP2784068A1 Phosphodiesterase 4 inhibitor capable of avoiding vomiting
10/01/2014EP2784065A1 Glycine reuptake inhibitor and use thereof
10/01/2014EP2784061A1 Acyl-hydrazone and oxadiazole compounds, pharmaceutical compositions containing the same and uses thereof
10/01/2014EP2783704A1 Pharmaceutical composition useful for adhesion prevention or hemostasis
10/01/2014EP2783701A2 Extended treatment of multiple sclerosis
10/01/2014EP2783700A1 Cancer stem cell-targeted cancer therapy
10/01/2014EP2783695A1 Physiological supplement or medicament for ophthalmic use containing L-carnitine or alkanoyl L-carnitines in combination with eledoisin
10/01/2014EP2783691A1 Polysialic acid and use for treatment of neurodegenerative and neuroinflammatory diseases
10/01/2014EP2783690A1 New use of neohesperidin
10/01/2014EP2783689A1 Keratoconjunctival protecting agent, or keratoconjunctival disorder inhibiting agent
10/01/2014EP2783688A1 Pharmaceutical tablets of crystalline type ii aripiprazole
10/01/2014EP2783687A1 Composition for inhibition of cathepsin K
10/01/2014EP2783686A1 Combination of a rapamycin derivative and letrozole for treating breast cancer
10/01/2014EP2783685A1 Use of levo-oxiracetam and oxiracetam in preparation of medicines for preventing or treating coma
10/01/2014EP2783684A1 Prenylflavanone compounds for modulating diabetes
10/01/2014EP2783682A1 Pharmaceutical composition comprising pimobendan
10/01/2014EP2783680A1 Controlled-release formulations comprising metformin and gliclazide
10/01/2014EP2783679A1 Drug carrier with chelating composite micell and use thereof
10/01/2014EP2782926A1 Peptide sequence design and use thereof for peptide-mediated sirna delivery
10/01/2014EP2782922A1 Antibacterial tylosin derivatives and methods for their preparation
10/01/2014EP2782917A1 Thienopyrimidine inhibitors of atypical protein kinase c
10/01/2014EP2782915A1 [1, 2, 3]triazolo [4, 5 -d]pyrimidine derivatives as agonists of the cannabinoid receptor 2 agonists
10/01/2014EP2782914A1 Method for producing substituted 5-fluoro-1h-pyrazolopyridines
10/01/2014EP2782912A1 Solid state forms of vilazodone and vilazodone hydrochloride
10/01/2014EP2782903A1 Novel pyrrolidine derivatives as inhibitors of cathepsin
10/01/2014EP2782902A2 Derivatives of phenoxyisobutyric acid
10/01/2014EP2782643A1 Androgen receptor ligands
10/01/2014EP2782612A1 Device for preventing and/or treating urinary tract infections
10/01/2014EP2782590A2 Radiation-sterilized biodegradable drug delivery compositions
10/01/2014EP2782586A1 Improved synergistic anti-diabetic compositions
10/01/2014EP2782585A1 Antiviral formulations
10/01/2014EP2782584A2 Natural combination hormone replacement formulations and therapies
10/01/2014EP2782583A2 Methods and compositions for reducing alcohol toxicity
10/01/2014EP2782582A2 Oil compositions and methods for increasing hair growth and/or preventing hair loss
10/01/2014EP2782581A1 Electrolyte purgatives
10/01/2014EP2782580A1 Selective kinase inhibitors
10/01/2014EP2782579A1 Pyrazine kinase inhibitors
10/01/2014EP2782577A2 Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
10/01/2014EP2782576A1 Sodium salt of (r)-3-[6-amino-pyridin-3-yl]-2-(1-cyclohexyl-1h-imidazol-4-yl)-propionic acid
10/01/2014EP2782575A1 Crystalline salts of r)-3-[6-amino-pyridin-3-yl]-2-(1-cyclohexyl-1h-imidazol-4-yl)-propionic acid
10/01/2014EP2782574A1 Salt of (r)-3-(6-amino-pyridin-3-yl)-2-(1-cyclohexyl-1h-imidazol-4-yl) ethyl propionate
10/01/2014EP2782573A1 1,4- dihydropyridine derivatives with hsp modulating activity
10/01/2014EP2782572A1 Use of fluopyram for controlling endoparasites
10/01/2014EP2782571A1 Heterocyclic compounds and uses thereof
10/01/2014EP2782570A1 Heterocyclic inhibitors of glutaminase
10/01/2014EP2782569A1 Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3h-imidazole derivatives for treating retinal diseases
10/01/2014EP2782568A1 Tetrahydrocannabivarin (thcv) for use in the protection of pancreatic islet cells
10/01/2014EP2782567A1 Disubstituted beta-lactones as inhibitors of n-acylethanolamine acid amidase (naaa)
10/01/2014EP2782566A1 L-serine compositions, methods and uses for treating neurodegenerative diseases and disorders
10/01/2014EP2782565A1 Use of aryl and hetaryl carboxamides as endoparasiticides
10/01/2014EP2782564A1 Cysteamine and/or cystamine for treating ischemic injury
1 ... 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 ... 7860